Ausgabe 1/1999
Inhalt (7 Artikel)
Vaccines prepared with sialyl-Tn and sialyl-Tn trimers using the 4-(4-maleimidomethyl)cyclohexane-1-carboxyl hydrazide linker group result in optimal antibody titers against ovine submaxillary mucin and sialyl-Tn-positive tumor cells
Govindaswami Ragupathi, Lisa Howard, Sarah Cappello, R. Rao Koganty, Dongxu Qiu, B. Michael Longenecker, Mark A. Reddish, Kenneth O. Lloyd, Philip O. Livingston
A phase I study of a HER2/neu bispecific antibody with granulocyte-colony-stimulating factor in patients with metastatic breast cancer that overexpresses HER2/neu
V. Pullarkat, Y. Deo, J. Link, L. Spears, V. Marty, R. Curnow, S. Groshen, C. Gee, J. S. Weber
Production and characterization of an anti-(MUC1 mucin) recombinant diabody
Graeme Denton, Kevin Brady, Benny K. C. Lo, Andrea Murray, C. Rosamund, L. Graves, Owen D. M. Hughes, Saul J. B. Tendler, Charles A. Laughton, Michael R. Price
Lack of evidence for an immunosuppressive role for MUC1
Stéphane Paul, Nadine Bizouarne, Annick Paul, Michael R. Price, Gunnar C. Hansson, Marie Paule Kieny, R. Bruce Acres
High frequency of T cell clonal expansions in primary human melanoma. Involvement of a dominant clonotype in autologous tumor recognition
Patrizia Pisarra, Roberta Mortarini, Stefania Salvi, Andrea Anichini, Giorgio Parmiani, Marialuisa Sensi
Cellular and humoral immune responses to MUC1 mucin and tandem-repeat peptides in ovarian cancer patients and controls
F. G. M. Snijdewint, S. von Mensdorff-Pouilly, A. H. Karuntu-Wanamarta, A. A. Verstraeten, I. van Zanten-Przybysz, P. Hummel, H. W. Nijman, P. Kenemans, J. Hilgers
CD95 Ligand expression enhances growth of murine renal cell carcinoma in vivo
Hiroaki Nishimatsu, Takumi Takeuchi, Tetsuo Ueki, Takahiro Kajiwara, Nobuo Moriyama, Toshimitsu Ishida, Baoxing Li, Tadao Kakizoe, Tadaichi Kitamura